BACKGROUND: A randomized controlled trial comparing sublingual with vaginal administration of misoprostol for medical management of silent miscarriages. METHODS: Eighty women who had silent miscarriages (<13 weeks) were randomized to receive 600 mg of misoprostol every 3 h for a maximum of three doses either sublingually or vaginally. RESULTS: The success rates of medical management were the same in both groups (87.5%; 95% CI: 74±95%). There were no serious complications. The incidence of diarrhoea was higher in the sublingual (70%) than the vaginal route (27.5%) (P < 0.005). Other side effects were similar in each group, although fatigue was experienced by more women in the sublingual group than in the vaginal group (65 versus 40%: P = 0.043). The overall acceptability of medical management was good. Most women would choose the medical method if they were allowed to choose again and would recommend the method to others. CONCLUSION: The current regimen of misoprostol is useful for the management of silent miscarriage in terms of complete miscarriage rate and patient acceptability. Sublingual misoprostol may offer an alternative for women who do not like repeated vaginal administration of the drug.
Introduction
Spontaneous miscarriages occur in 15% of all ®rst trimester pregnancies (Laferia, 1986) . Surgical evacuation of the uterus used to be the standard management but is associated with side effects such as infection, perforation of uterus or Asherman's syndrome. The future fertility of the women may be jeopardized. A study in Hong Kong reported an overall complication rate of 6.6% with the surgical method (Chung et al., 1997) . Expectant management of miscarriages is an attractive option. It follows the natural history of the disease, avoids iatrogenic problems and is likely to be cost-effective. However, the incidence of the complete abortion rate is variable depending on the duration of observation (Nielsen and Hahlin, 1995; Jurkovic et al., 1998) . Expectant management may be useful in selected patients but the unpredictable success rate makes it unacceptable to some patients as a routine method of management.
Medical management has recently been explored as an alternative for management of miscarriage. Several studies have examined the ef®cacy of prostaglandins with or without mifepristone. It is dif®cult to make a conclusion from the available reports in the literature as to which regimen is the best, due to differences in the selection criteria, choice and dosage of medication and different criteria for the diagnosis of complete miscarriage. It would be desirable to develop a regimen without mifepristone since it is expensive and is not available in many countries. Misoprostol is the prostaglandin of choice as it is cheap and stable at room temperature. Various routes of administration including oral, vaginal and sublingual misoprostol have been studied for termination of pregnancy in the ®rst trimester (El-Refaey et al., 1995; Tang et al., 2002a,b) . Clinical studies have shown that vaginal is superior to oral misoprostol in termination of ®rst trimester pregnancies (El-Refaey et al., 1995) . Pilot studies have shown that sublingual misoprostol with or without mifepristone is useful in ®rst trimester medical abortion (Tang et al., 2002a,b) . A pharmacokinetic study has shown that sublingual misoprostol has the highest bioavailability and shortest time to peak concentration among the three different routes of administration (Tang et al., 2002c) . A pilot study has shown that repeated doses of sublingual misoprostol are useful in medical management of ®rst trimester miscarriages, with a success rate of 92% . It is the objective of this randomized trial to compare repeated doses of sublingual with vaginal misoprostol in the medical management of ®rst trimester miscarriages.
Materials and methods
A total of 80 women with a diagnosis of ®rst trimester silent miscarriage of <13 weeks gestation was recruited. An ultrasound examination was performed for all women to con®rm the following diagnosis of silent miscarriage (Bernard and Cooperberg, 1985) : (i) intrauterine gestational sac with a mean sac diameter of b2 cm without fetal pole; (ii) presence of fetal pole with no cardiac pulsation; (iii) the gestational sac was <2 cm with no interval growth or persistent absence of fetal cardiac pulsation on rescanning 7±10 days later. Women with complete or incomplete miscarriages were excluded. The study protocol was approved by the Ethics Committee, Faculty of Medicine, University of Hong Kong.
The 80 women were randomized according to computer-generated random numbers into two groups. Women in group 1 received 600 mg misoprostol sublingually every 3 h for a maximum of three doses and group 2 received 600 mg misoprostol vaginally every 3 h for a maximum of three doses. Informed consent was obtained before randomization. The women in group 1 were instructed by the investigator to put the three misoprostol tablets under the tongue themselves. They were not allowed any food or drink for the next 20 min to allow complete dissolution of the tablets. The research nurse was responsible for the administration of vaginal misoprostol in group 2 by putting the three misoprostol tablets into the posterior fornix. The blood pressure, pulse rate and side effects were recorded every hour and the body temperature was recorded every 3 h. Oral or parenteral analgesic was given if the woman complained of severe pain. The women were discharged after completion of the course of misoprostol if there was no heavy vaginal bleeding and they were not in pain. The women were asked to inform the nurse when they passed the product of conception at the hospital and they were given a bottle with formalin to collect any product of conception passed at home. The product of conception was sent for histological con®rmation. Emergency surgical evacuation was performed if the blood loss or abdominal pain was uncontrolled. All the women were asked to use a barrier method for contraception if necessary. The outcome of the treatment was ®rst assessed on day 7 after misoprostol. A transvaginal ultrasound examination of the pelvis was performed. Surgical evacuation was conducted if a gestational sac was still present or if there was a signi®cant amount of the products of conception in the uterus together with clinical evidence of heavy vaginal bleeding. If the ultrasound examination showed evidence of complete or incomplete miscarriage without heavy vaginal bleeding, no action would be taken. The amount of bleeding was monitored and the woman was asked to come back on day 43 to ascertain the bleeding pattern and return of menstruation. The outcome of treatment was classi®ed as complete miscarriage if surgical evacuation was not required up to the time of return of normal menstruation.
The primary outcome measure was the complete miscarriage rate. The incidence of side effects and the change in haemoglobin level were also studied. The acceptability of each method was assessed by questionnaire. Differences in continuous variables were analysed with Student's t-test for normally distributed data and the Mann±Whitney U-tests for skewed data. Differences in discontinuous variables were analysed by c 2 -test and Fisher's exact test as appropriate.
The difference in complete miscarriage rate was used to calculate the sample size required. According to the previous studies, the use of vaginal misoprostol would achieve a complete miscarriage rate of 60% (Chung et al., 1995) . Sublingual misoprostol would be superior to vaginal misoprostol if it could achieve a complete miscarriage rate of 90%. Assuming that 5% of the data were excluded retrospectively, a sample size of 40 in each group would give 80% power in detecting a difference of 30% in the complete miscarriage rate with an alpha of 0.05.
Results
The demographic characteristics of the 80 women who underwent medical management of miscarriages are shown in Table I . There were no signi®cant differences between the two groups with respect to the age, weight, height and gestational age. The complete miscarriage rate was the same for both groups (87.5%; 95% CI: 74±95%) (Table II) . The median duration between the administration of the misoprostol tablets and the start of vaginal bleeding was 2.5 and 3.0 h respectively for sublingual and vaginal misoprostol. A total of 82.5 and 75% of the women in the sublingual and vaginal groups respectively reported passage of the product of conception with the ®rst 24 h. The median induction to expulsion intervals were 9.5 and 13.5 h in the sublingual and vaginal groups respectively. However, the differences were not statistically signi®cant. The median days of vaginal bleeding after abortion were similar in both groups. There was no signi®cant change in the haemoglobin level before and after abortion in both groups. Eight women had surgical evacuation. One woman had the operation carried out on day 7 for silent miscarriage and this was considered to be treatment failure. The other seven women had the operation carried out in the other hospitals after the ®rst follow-up visit because of persistent vaginal bleeding. The side effect pro®les are shown (Table III ). The incidences of diarrhoea and fatigue were higher in the sublingual group.
The acceptability of the medical management of miscarriage was assessed by questionnaire on days 7 and 43 (Table IV) . Most of the women chose medical management this time because they were worried about the risks and complications of surgery and its effect on future pregnancy. At least 80% of the women in either group thought that the degree of pain was tolerable and expected. The duration of vaginal bleeding after miscarriage was also acceptable to most of them. About 80±85% of the women in either group said they would prefer the medical method if both medical and surgical treatments were equally effective. Most of them would still choose medical methods if they were allowed to opt again. Over 70% of the women said that the medical method was a satisfactory method for the management of miscarriages.
Discussion
Surgical evacuation is the standard practice for the management of miscarriage in many parts of the world. It is an effective method with a success rate of up to 98% (Chung et al., 1998) . However, it may be associated with serious complications such as post-abortion pelvic infection, perforation of the uterus, cervical injury and Asherman's syndrome. Many of these complications are irreversible and can seriously compromise future fertility. Expectant and medical management are recent alternative methods being investigated for the management of silent miscarriages. Expectant management follows the natural course of miscarriage. The success rate ranged from 25±85% depending on whether incomplete miscarriages were included (Hurd et al., 1997; Jurkovic et al., 1998; Nielsen et al., 1999; Ngai et al., 2001) . The success rate decreased to 50% if only silent miscarriages were included (Jurkovic et al., 1998; Ngai et al., 2001) . The time required for complete miscarriage to occur is variable in expectant management. It was reported that only 40% of the women accepted the offer of expectant management and another 60% of the women requested surgery after 48 h (Jurkovic et al., 1998) . This may be due to the uncertainty in predicting the success of expectant management. In another report, a higher proportion of women had surgery in the expectant group compared with the medical management group either due to the patient's or the doctor's decision (Ngai et al., 2001) . The long observation time may be one of the reasons for both the patient and the doctor to turn to surgery while waiting for the passage of product of conception. Therefore medical management may be a better alternative. The acceptability of medical management was good in this study. Most of the women would choose medical treatment again if they were allowed to choose and most of the women accepted the route of administration to which they were randomized. There are two limitations in the assessment of the acceptability of the method in this study. Firstly, the subjects might not have the experience of surgical evacuation and therefore, it was dif®cult for them to compare the two methods and decide which was the preferred method to them. Secondly, this was an open study and the subjects knew the route of administration that they were assigned. The outcome of the treatment might affect their preference. This was demonstrated by the fact that 95% of the women who preferred medical management in both arms had a complete miscarriage whereas only about 60% of the women who preferred surgical treatment had a complete miscarriage. The situation was the same for the preference on the route of administration. Over 90% of the subjects who preferred the route of administration to which they were assigned had a complete miscarriage whereas only 70±80% of the subjects who preferred the other route of administration had a complete miscarriage. This indicated that the outcome of treatment might affect the women's preference on the route of administration. A double-blinded placebo controlled trial may be able to tell us which route is more acceptable. Nevertheless, this study showed that most of the women thought that medical management was an acceptable method and both routes of administration were acceptable to those who had used them. This was especially true for those who had a successful outcome. Since the success rates for both routes of administration were high, medical management by either sublingual or vaginal routes was an acceptable method to most of the women in this study. The use of mifepristone together with a prostaglandin analogue has been used in the termination of ®rst trimester pregnancy with a high complete abortion rate of >95% (El-Refaey et al., 1995) . The success rate was reported to be 84% in ®rst trimester silent miscarriage using a combination of mifepristone and repeated doses of misoprostol (Wagaarachchi et al., 2001) . However, it is believed that mifepristone may not be necessary for medical management of miscarriages as the pregnancy is non-viable. Moreover, mifepristone is expensive and is not available in many countries. Regimens using prostaglandin alone would be more practical in many countries where mifepristone is not available. Misoprostol is the prostaglandin of choice as it is cheap and stable at room temperature. It has been used orally and vaginally for medical abortion and management of miscarriage (El-Refaey et al., 1995; Chung et al., 1997; Ngai et al., 2001) . Most studies have shown that the vaginal route of administration is more effective and gives a higher complete abortion rate. However, the oral route is more convenient and acceptable (Ho et al., 1997) . This is especially true for regimens using misoprostol alone because repeated administration is required. Recently, the sublingual route of adminis- Excellent 4 (10) 3 (7.5) Satisfactory 26 (65) 28 (70) Fair 6 (15) 5 (12.5) Not satisfactory 2 (5) 3 (7.5) a The subjects were allow to choose more than one answer. b A total of 36 women in the sublingual and 38 women in the vaginal group gave answers to this question. c A total of 38 women in the sublingual and 39 women in the vaginal group gave answers to questions related to the preference of methods. Percentages are shown in parentheses.
tration of misoprostol has been investigated. This may offer an alternative for women who do not like vaginal drug administration. It may be a better way of giving the drug in cases of heavy vaginal bleeding, which may affect the absorption in vaginal administration. This is especially true for regimens that require repeated doses of misoprostol. Pilot studies have shown that it was effective for medical abortion and management of miscarriage Tang et al., 2002a) . A pharmacological study has also shown that sublingual misoprostol gave the shortest time to peak serum concentration and greatest systemic bioavailability (Tang et al., 2002c) . This means that sublingual misoprostol may have the most potent and fastest onset of action compared with the other routes of administration.
There have been very few randomized trials that compared different regimens of misoprostol in the management of miscarriages. Many of these studies involved subjects with incomplete miscarriages in whom the response to misoprostol may be better (Chung et al., 1995; Chung et al., 1997; Nielsen and Hahlin, 1995; Nielsen et al., 1999; Ngai et al., 2001) . The studies that included silent miscarriages alone were not randomized studies (El-Refaey, 1992; Zalanyi, 1998; Wagaarachchi et al., 2001) . The present randomized study has demonstrated that medical management is an effective method for the management of silent miscarriages. Both vaginal and sublingual misoprostol gave a success rate of 87.5%. This compared favourably with our previous study using a different regimen of vaginal misoprostol (400 mg on days 1, 3 and 5) which resulted in a complete miscarriage rate of 83.3%. In that study, the expectant arm had a complete miscarriage rate of 48.3% over a 2 week observation period and the complete miscarriage rate for this group of women was even lower if only silent miscarriages were included (31.6%) (Ngai et al., 2001) . The advantage of the present regimen is that it can be completed over 1 day and there is no need for repeated follow-up visits for the administration of misoprostol. Most of the subjects who had complete miscarriage passed the product of conception within the ®rst 24 h. Therefore, they would be more certain about the outcome of treatment after they had completed the course of misoprostol. The complete miscarriage rate is also similar to a study using a combination of mifepristone and repeated doses of misoprostol which resulted in a success rate of 84.1% (Wagaarachchi et al., 2001) . It seems that the addition of mifepristone does not increase the complete miscarriage rate. A randomized trial is required to con®rm this.
The de®nition of success of treatment varies among different studies in the literature. Most of the studies used ultrasonographical evidence of an empty uterus as the de®nition of success of treatment (Chung et al., 1995 (Chung et al., , 1997 (Chung et al., , 1998 Nielsen et al., 1999) . It is well known that women with incomplete miscarriages diagnosed by ultrasound examination may not require surgical evacuation. It was suggested that the need for surgical evacuation after miscarriage should be indicated by clinical rather that ultrasonographical criteria (Ankum et al., 2001) . In the present study, treatment failure was de®ned as the presence of an intrauterine gestational sac on day 7. The need for surgical evacuation for incomplete miscarriage was dictated by clinical rather than ultrasonographical criteria. The duration of the observation period may also affect the success rate. In many of the previous studies, ultrasound examination was performed within the ®rst day after misoprostol and surgical evacuation was carried out if there was evidence of retained product of conception (Chung et al., 1995 (Chung et al., , 1997 (Chung et al., , 1998 Nielsen et al., 1999) . We believe that a waiting period of 7 days can optimize the success rate, as we know from medical termination of pregnancy that the passage of the product of conception may be delayed after misoprostol. The percentage of unnecessary surgical evacuation may be increased if the outcome is assessed immediately after misoprostol. This is the ®rst randomized trial comparing the clinical uses of sublingual versus vaginal misoprostol. The clinical ef®cacy of sublingual misoprostol is the same as vaginal misoprostol. The interval between misoprostol and passage of the product of conception was slightly shorter in the sublingual group and there was also a higher proportion of women in the sublingual group who had passed the product of conception within the ®rst 24 h. However, statistically signi®cant differences could not be demonstrated for these two parameters, probably due to the small sample size. Previous pilot studies have shown that there might be a higher incidence of side effects for sublingual misoprostol, especially for chills and fever (Tang et al., 2002a,c) . In this randomized trial, the side effect pro®le was actually quite similar in both groups except for diarrhoea and fatigue, which were shown to be signi®cantly more frequent in the sublingual group. However, this did not affect the acceptability of sublingual misoprostol. Most of the women in the sublingual group would still use the same method if they were allowed to choose again and would also recommend the method to others.
In conclusion, the overall ef®cacy and acceptability of medical management of silent miscarriage were good. Most women would like to be treated medically if both the surgical and the medical method were of the same ef®cacy. Both sublingual and vaginal misoprostol result in the same complete miscarriage rate. The induction±miscarriage interval might be shorter in sublingual misoprostol but a larger randomized trial is required to con®rm this. Nevertheless, sublingual misoprostol can be offered to women who do not like repeated vaginal administration. There is a potential to develop the sublingual administration of misoprostol into a self-administered outpatient regimen.
